Observation of hypertension in children with 21-hydroxylase deficiency: a preliminary report

Todd D Nebesio1, Erica A Eugster

  • 1Department of Pediatrics, Section of Pediatric Endocrinology/Diabetology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA. tdnebesi@iupui.edu

Endocrine
|May 29, 2007
PubMed

Insights

Hypertension (HTN) is more common in children with 21-hydroxylase deficiency (21OHD) than previously thought. Elevated BMI did not predict HTN development in this pediatric endocrine disorder.

Area of Science:

  • Pediatric Endocrinology
  • Genetics and Genetic Diseases
  • Cardiovascular Health

Background:

  • 21-hydroxylase deficiency (21OHD) is the primary cause of congenital adrenal hyperplasia.
  • The prevalence and risk factors for hypertension (HTN) in pediatric patients with 21OHD remain largely uncharacterized.
  • Obesity is a known risk factor for HTN in the general pediatric population, prompting investigation into its role in 21OHD.

Purpose of the Study:

  • To determine the prevalence of hypertension in children diagnosed with 21-hydroxylase deficiency.
  • To investigate whether elevated body mass index (BMI) is a predictive factor for the development of hypertension in this cohort.
  • To compare the observed HTN prevalence in children with 21OHD to historical pediatric data.

Main Methods:

  • Retrospective chart review of pediatric patients with 21OHD treated at pediatric endocrine clinics over a 21-year period.
  • Identification of patients diagnosed with 21OHD and assessment for the presence of hypertension.
  • Analysis of body mass index (BMI) as a potential predictor for hypertension development.

Main Results:

  • A total of 91 children with 21OHD were included in the study.
  • Six patients (6.6%) were diagnosed with hypertension, with five (5.6%) having essential hypertension.
  • Elevated BMI was not found to be a significant determining factor in the development of HTN among these children.

Conclusions:

  • Children with 21OHD exhibit a higher prevalence of hypertension compared to historical pediatric population data.
  • Elevated BMI is not a predictive factor for HTN in children with 21OHD.
  • The co-occurrence of HTN with salt-wasting and mineralocorticoid deficiency in some 21OHD patients presents a paradoxical clinical picture requiring further etiological investigation.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...